![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Bmp5 | Rat | 17beta-estradiol | affects expression | ISO | BMP5 (Homo sapiens) | 6480464 | Estradiol affects the expression of BMP5 mRNA | CTD | PMID:14699072 | Bmp5 | Rat | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of BMP5 mRNA | CTD | PMID:32145629 | Bmp5 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Bmp5 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | Bmp5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BMP5 mRNA | CTD | PMID:24035824 and PMID:26290441 | Bmp5 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Bmp5 (Mus musculus) | 6480464 | bisphenol S results in increased expression of BMP5 mRNA | CTD | PMID:30951980 | Bmp5 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Bmp5 (Mus musculus) | 6480464 | bisphenol S affects the methylation of BMP5 gene | CTD | PMID:31683443 | Bmp5 | Rat | 5-aza-2'-deoxycytidine | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Decitabine results in decreased expression of BMP5 mRNA | CTD | PMID:27915011 | Bmp5 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of BMP5 mRNA | CTD | PMID:30047161 | Bmp5 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of BMP5 mRNA | CTD | PMID:31881176 | Bmp5 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of BMP5 mRNA | CTD | PMID:28959563 | Bmp5 | Rat | aflatoxin B1 | decreases methylation | ISO | BMP5 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of BMP5 gene | CTD | PMID:27153756 | Bmp5 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of BMP5 mRNA | CTD | PMID:35163327 | Bmp5 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of BMP5 mRNA | CTD | PMID:30047161 | Bmp5 | Rat | arotinoid acid | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 | Bmp5 | Rat | arsane | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Arsenic results in decreased expression of BMP5 mRNA | CTD | PMID:19654921 | Bmp5 | Rat | arsenic atom | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Arsenic results in decreased expression of BMP5 mRNA | CTD | PMID:19654921 | Bmp5 | Rat | arsenite(3-) | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | arsenite results in decreased expression of BMP5 mRNA | CTD | PMID:33053406 | Bmp5 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of BMP5 gene | CTD | PMID:35440735 | Bmp5 | Rat | belinostat | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA | CTD | PMID:27188386 | Bmp5 | Rat | belinostat | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | belinostat results in increased expression of BMP5 mRNA | CTD | PMID:26272509 | Bmp5 | Rat | benzo[a]pyrene | increases methylation | ISO | Bmp5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of BMP5 intron | CTD | PMID:27901495 | Bmp5 | Rat | benzo[a]pyrene | increases methylation | ISO | BMP5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of BMP5 exon | CTD | PMID:27901495 | Bmp5 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of BMP5 mRNA | CTD | PMID:25181051 more ... | Bmp5 | Rat | bisphenol A | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of BMP5 mRNA | CTD | PMID:33221593 | Bmp5 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of BMP5 mRNA | CTD | PMID:32145629 | Bmp5 | Rat | bisphenol A | increases expression | ISO | Bmp5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of BMP5 mRNA | CTD | PMID:30951980 | Bmp5 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of BMP5 gene | CTD | PMID:28505145 | Bmp5 | Rat | bisphenol F | increases expression | ISO | Bmp5 (Mus musculus) | 6480464 | bisphenol F results in increased expression of BMP5 mRNA | CTD | PMID:30951980 | Bmp5 | Rat | cadmium dichloride | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of BMP5 mRNA | CTD | PMID:27375191 | Bmp5 | Rat | carbon nanotube | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of BMP5 mRNA | CTD | PMID:25554681 | Bmp5 | Rat | carmustine | affects response to substance | ISO | BMP5 (Homo sapiens) | 6480464 | BMP5 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 | Bmp5 | Rat | carnosic acid | multiple interactions | ISO | Bmp5 (Mus musculus) | 6480464 | salvin inhibits the reaction [sodium arsenite results in decreased expression of BMP5 mRNA] | CTD | PMID:35202923 | Bmp5 | Rat | CHIR 99021 | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 | Bmp5 | Rat | chlorambucil | increases mutagenesis | ISO | Bmp5 (Mus musculus) | 6480464 | Chlorambucil results in increased mutagenesis of BMP5 gene | CTD | PMID:10517996 | Bmp5 | Rat | chlordecone | increases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Chlordecone results in increased expression of BMP5 mRNA | CTD | PMID:29980752 | Bmp5 | Rat | chloroprene | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of BMP5 mRNA | CTD | PMID:23125180 | Bmp5 | Rat | cortisol | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 | Bmp5 | Rat | coumestrol | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of BMP5 mRNA | CTD | PMID:19167446 | Bmp5 | Rat | cytarabine | decreases expression | ISO | BMP5 (Homo sapiens) | 6480464 | Cytarabine results in decreased expression of BMP5 mRNA | CTD | PMID:21198554 | Bmp5 | Rat | dimethylarsinic acid | decreases expression | EXP | | 6480464 | Cacodylic Acid results in decreased expression of BMP5 mRNA | CTD | PMID:37567419 | Bmp5 | Rat | dorsomorphin | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Bmp5 | Rat | doxorubicin | affects expression | ISO | BMP5 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of BMP5 mRNA | CTD | PMID:29803840 | Bmp5 | Rat | entinostat | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA | CTD | PMID:27188386 | Bmp5 | Rat | entinostat | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | entinostat results in increased expression of BMP5 mRNA | CTD | PMID:26272509 and PMID:27188386 | Bmp5 | Rat | genistein | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Genistein results in decreased expression of BMP5 mRNA | CTD | PMID:32186404 | Bmp5 | Rat | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of BMP5 gene | CTD | PMID:35440735 | Bmp5 | Rat | glyphosate | decreases expression | ISO | BMP5 (Homo sapiens) | 6480464 | Glyphosate results in decreased expression of BMP5 mRNA | CTD | PMID:31295307 | Bmp5 | Rat | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of BMP5 mRNA | CTD | PMID:21396975 | Bmp5 | Rat | indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA | CTD | PMID:22129741 | Bmp5 | Rat | kojic acid | decreases expression | ISO | BMP5 (Homo sapiens) | 6480464 | kojic acid results in decreased expression of BMP5 mRNA | CTD | PMID:16595896 | Bmp5 | Rat | L-ascorbic acid | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA | CTD | PMID:34480604 | Bmp5 | Rat | L-ascorbic acid 2-phosphate | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA | CTD | PMID:34480604 | Bmp5 | Rat | lipopolysaccharide | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | Bmp5 | Rat | lipopolysaccharide | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of BMP5 mRNA | CTD | PMID:35811015 | Bmp5 | Rat | mercury dibromide | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of BMP5 mRNA | CTD | PMID:26272509 | Bmp5 | Rat | mercury dibromide | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA | CTD | PMID:27188386 | Bmp5 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of BMP5 mRNA | CTD | PMID:30047161 | Bmp5 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of BMP5 gene | CTD | PMID:35440735 | Bmp5 | Rat | methylmercury chloride | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of BMP5 mRNA | CTD | PMID:28001369 | Bmp5 | Rat | microcystin-LR | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | cyanoginosin LR results in increased expression of BMP5 mRNA | CTD | PMID:29518473 | Bmp5 | Rat | mono(2-ethylhexyl) phthalate | decreases expression | ISO | BMP5 (Homo sapiens) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of BMP5 mRNA | CTD | PMID:36695872 | Bmp5 | Rat | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA | CTD | PMID:22129741 | Bmp5 | Rat | N-ethyl-N-nitrosourea | increases mutagenesis | ISO | Bmp5 (Mus musculus) | 6480464 | Ethylnitrosourea results in increased mutagenesis of BMP5 gene | CTD | PMID:10517996 more ... | Bmp5 | Rat | N-methyl-4-phenylpyridinium | decreases expression | ISO | BMP5 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of BMP5 mRNA | CTD | PMID:24810058 | Bmp5 | Rat | N-methyl-N-nitrosourea | increases mutagenesis | ISO | Bmp5 (Mus musculus) | 6480464 | Methylnitrosourea results in increased mutagenesis of BMP5 gene | CTD | PMID:10517996 and PMID:17174358 | Bmp5 | Rat | N-nitrosodiethylamine | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Diethylnitrosamine results in decreased expression of BMP5 mRNA | CTD | PMID:24535843 | Bmp5 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA | CTD | PMID:22129741 | Bmp5 | Rat | N-nitrosodiethylamine | multiple interactions | ISO | Bmp5 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BMP5 mRNA | CTD | PMID:24535843 | Bmp5 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of BMP5 mRNA | CTD | PMID:25729387 | Bmp5 | Rat | p-chloromercuribenzoic acid | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of BMP5 mRNA | CTD | PMID:26272509 | Bmp5 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA | CTD | PMID:27188386 | Bmp5 | Rat | panobinostat | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA | CTD | PMID:27188386 | Bmp5 | Rat | panobinostat | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | panobinostat results in increased expression of BMP5 mRNA | CTD | PMID:26272509 | Bmp5 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of BMP5 mRNA | CTD | PMID:35163327 | Bmp5 | Rat | phenobarbital | multiple interactions | ISO | Bmp5 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BMP5 mRNA | CTD | PMID:24535843 | Bmp5 | Rat | phenobarbital | affects expression | ISO | Bmp5 (Mus musculus) | 6480464 | Phenobarbital affects the expression of BMP5 mRNA | CTD | PMID:23091169 | Bmp5 | Rat | phenylmercury acetate | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of BMP5 mRNA | CTD | PMID:26272509 | Bmp5 | Rat | phenylmercury acetate | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA | CTD | PMID:27188386 | Bmp5 | Rat | pirinixic acid | multiple interactions | ISO | Bmp5 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BMP5 mRNA | CTD | PMID:19710929 | Bmp5 | Rat | potassium dichromate | increases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of BMP5 mRNA | CTD | PMID:23608068 | Bmp5 | Rat | progesterone | multiple interactions | ISO | Bmp5 (Mus musculus) | 6480464 | NCOA2 protein affects the reaction [Progesterone results in decreased expression of BMP5 mRNA] and PGR protein affects the reaction [Progesterone results in decreased expression of BMP5 mRNA] | CTD | PMID:17556502 | Bmp5 | Rat | progesterone | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Progesterone results in decreased expression of BMP5 mRNA | CTD | PMID:17556502 | Bmp5 | Rat | resveratrol | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of BMP5 mRNA | CTD | PMID:19167446 | Bmp5 | Rat | rotenone | decreases expression | ISO | BMP5 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of BMP5 mRNA | CTD | PMID:29955902 | Bmp5 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | Bmp5 | Rat | SB 431542 | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:34480604 | Bmp5 | Rat | sodium arsenate | increases expression | ISO | Bmp5 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of BMP5 mRNA | CTD | PMID:21795629 | Bmp5 | Rat | sodium arsenite | decreases expression | ISO | BMP5 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of BMP5 mRNA | CTD | PMID:19615344 | Bmp5 | Rat | sodium arsenite | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of BMP5 mRNA | CTD | PMID:35202923 and PMID:37682722 | Bmp5 | Rat | sodium arsenite | multiple interactions | ISO | Bmp5 (Mus musculus) | 6480464 | salvin inhibits the reaction [sodium arsenite results in decreased expression of BMP5 mRNA] | CTD | PMID:35202923 | Bmp5 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of BMP5 mRNA | CTD | PMID:30047161 | Bmp5 | Rat | sunitinib | decreases expression | ISO | BMP5 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of BMP5 mRNA | CTD | PMID:31533062 | Bmp5 | Rat | tamoxifen | affects expression | ISO | BMP5 (Homo sapiens) | 6480464 | Tamoxifen affects the expression of BMP5 mRNA | CTD | PMID:14699072 | Bmp5 | Rat | temozolomide | affects response to substance | ISO | BMP5 (Homo sapiens) | 6480464 | BMP5 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 | Bmp5 | Rat | tetrachloroethene | increases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of BMP5 mRNA | CTD | PMID:28973375 | Bmp5 | Rat | tetrachloromethane | decreases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of BMP5 mRNA | CTD | PMID:17484886 | Bmp5 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of BMP5 mRNA | CTD | PMID:25729387 | Bmp5 | Rat | trichostatin A | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of BMP5 mRNA | CTD | PMID:24935251 and PMID:26272509 | Bmp5 | Rat | trichostatin A | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA | CTD | PMID:27188386 | Bmp5 | Rat | valproic acid | decreases methylation | ISO | BMP5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of BMP5 gene | CTD | PMID:29154799 | Bmp5 | Rat | valproic acid | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA | CTD | PMID:27188386 | Bmp5 | Rat | valproic acid | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of BMP5 mRNA | CTD | PMID:23179753 more ... | Bmp5 | Rat | valproic acid | increases expression | ISO | Bmp5 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of BMP5 mRNA | CTD | PMID:24896083 | Bmp5 | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of BMP5 mRNA | CTD | PMID:22615374 | Bmp5 | Rat | vorinostat | increases expression | ISO | BMP5 (Homo sapiens) | 6480464 | vorinostat results in increased expression of BMP5 mRNA | CTD | PMID:26272509 and PMID:27188386 | Bmp5 | Rat | vorinostat | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA | CTD | PMID:27188386 | Bmp5 | Rat | XAV939 | multiple interactions | ISO | BMP5 (Homo sapiens) | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA | CTD | PMID:34480604 | |